Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

SOLIFENACIN SUCCINATE CRS (5 MG)

SOLIFENACIN SUCCINATE CRS (5 MG)

242478-38-2

DISCOVER
CENTELLA DRY EXTRACT HRS (150MG)

CENTELLA DRY EXTRACT HRS (150MG)

NA

DISCOVER
LAUDANOSINE CRS (15 MG)

LAUDANOSINE CRS (15 MG)

1699-51-0

DISCOVER
CISATRACURIUM BESILATE CRS (130 MG)

CISATRACURIUM BESILATE CRS (130 MG)

96946-42-8

DISCOVER
CISATRACURIUM FOR SYSTEM SUITABILITY CRS (5 MG)

CISATRACURIUM FOR SYSTEM SUITABILITY CRS (5 MG)

NA

DISCOVER
CISATRACURIUM FOR PEAK IDENTIFICATION CRS (5 MG)

CISATRACURIUM FOR PEAK IDENTIFICATION CRS (5 MG)

NA

DISCOVER
PIRFENIDONE CRS (120 MG)

PIRFENIDONE CRS (120 MG)

53179-13-8

DISCOVER
MEDRONATE FOR RADIOCHEMICAL PURITY TESTING CRS (5 MG)

MEDRONATE FOR RADIOCHEMICAL PURITY TESTING CRS (5 MG)

NA

DISCOVER
OXIDRONATE FOR RADIOCHEMICAL PURITY TESTING CRS (34 MG)

OXIDRONATE FOR RADIOCHEMICAL PURITY TESTING CRS (34 MG)

14255-61-9

DISCOVER
SODIUM LAUROYLSARCOSINATE CRS(550 MG)

SODIUM LAUROYLSARCOSINATE CRS(550 MG)

137-16-6

DISCOVER
ROPINIROLE HYDROCHLORIDE CRS (125 MG)

ROPINIROLE HYDROCHLORIDE CRS (125 MG)

91374-20-8

DISCOVER
ROPINIROLE IMPURITY A CRS (25MG)

ROPINIROLE IMPURITY A CRS (25MG)

NA

DISCOVER